Jacobs Levy Equity Management
STAB

Jacobs Levy Equity Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Jacobs Levy Equity Management’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-5,762
Closed -$135K – 1034
2013
Q4 		$135K Buy
5,762
+2,305
+67% +$62.7K ﹤0.01% 896
2013
Q3 		$109K Sell
3,457
-4,579
-57% -$151K ﹤0.01% 885
2013
Q2 		$254K Buy
+8,036
New +$277K ﹤0.01% 855

Other funds holding STAB

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Jacobs Levy Equity Management's STAB Position: Q1 2014 in Review

Jacobs Levy Equity Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2014, closing a stake of 5,762 shares — an estimated $135K sold.

Jacobs Levy Equity Management first reported a position in STAB in Q2 2013 and held it in 3 quarters. The position peaked at $254K in Q2 2013. 35 funds tracked by Wall St. Rank hold STAB as of Q1 2014.

  • Jacobs Levy Equity Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 5,762 Statera Biopharma, Inc. Common Stock shares in Q1 2014, an estimated $135K.
  • Jacobs Levy Equity Management first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
  • Jacobs Levy Equity Management's Statera Biopharma, Inc. Common Stock position peaked at $254K in Q2 2013.
  • 35 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2014.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2014, filed 15 May 2014.